Literature DB >> 22920530

Thoracoscopic mediastinal lymph node dissection for lung cancer.

Hyun-Sung Lee1, Hee-Jin Jang.   

Abstract

Mediastinal lymph node staging is an important component of the assessment and management of patients with operable non-small cell lung cancer and is necessary to achieve complete resection. During minimally invasive surgery, performance of an equivalent oncologic resection, including adequate lymph node dissection similar in extent to open thoracotomy, is absolutely necessary. We describe our techniques for video-assisted thoracic surgery (VATS) and Robot-assisted VATS (R-VATS) mediastinal lymph node dissection when performing thoracoscopic lobectomy for lung cancer. Between 2008 and 2011, 200 consecutive patients who underwent VATS or R-VATS lobectomies for early stage lung cancer were analyzed. In our series, we removed about 25 lymph nodes per case in both complete VATS and R-VATS. A thorough lymph node dissection in lung cancer is possible with either VATS or R-VATS technique without oncological compromise.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22920530     DOI: 10.1053/j.semtcvs.2012.02.004

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  17 in total

1.  Video-assisted thoracoscopic surgery non-grasping en bloc mediastinal lymph node dissection for the right side.

Authors:  Lin Ma; Chengwu Liu; Jiandong Mei; Yanbo Yang; Lunxu Liu
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Robot-assisted thoracoscopic surgery: current status and prospects.

Authors:  Hiroshige Nakamura; Yuji Taniguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-30

3.  Efficacy of lymph node dissection during robotic-assisted lobectomy for non-small cell lung cancer: retrospective review of 159 consecutive cases.

Authors:  Frank O Velez-Cubian; Kathryn L Rodriguez; Matthew R Thau; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Technical and operational modifications required for evolving robotic programs performing anatomic pulmonary resection.

Authors:  Benjamin Smood; Asem Ghanim; Benjamin Wei; Robert J Cerfolio
Journal:  J Robot Surg       Date:  2018-01-23

5.  The management of doornail lymph node in lobectomy.

Authors:  Xiuyuan Chen; Yun Li; Xizhao Sui; Zuli Zhou; Jun Wang
Journal:  J Vis Surg       Date:  2016-01-13

6.  Body surface area: a novel predictor for conversion to thoracotomy in patients undergoing video-assisted thoracoscopic lung cancer lobectomy.

Authors:  Shuang-Jiang Li; Kun Zhou; Cheng Shen; Peng-Fei Li; Yan-Ming Wu; Zhi-Qiang Wang; Guo-Wei Che
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

7.  A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.

Authors:  Martin Reichert; Dagmar Steiner; Stefanie Kerber; Julia Bender; Bernd Pösentrup; Andreas Hecker; Johannes Bodner
Journal:  Surg Endosc       Date:  2015-07-14       Impact factor: 4.584

8.  Video-assisted thoracoscopic surgery for non-small-cell lung cancer in elderly patients: a single-center, case-matched study.

Authors:  Keqiang Liu; Jing Zhao; Weiqiang Zhang; Jian Tan; Jingbo Ma; Yingxin Pei
Journal:  Int J Clin Exp Med       Date:  2015-07-15

9.  A propensity score matching study of non-grasping en bloc mediastinal lymph node dissection versus traditional grasping mediastinal lymph node dissection for non-small cell lung cancer by video-assisted thoracic surgery.

Authors:  Chenglin Guo; Liang Xia; Jiandong Mei; Chengwu Liu; Feng Lin; Lin Ma; Qiang Pu; Lunxu Liu
Journal:  Transl Lung Cancer Res       Date:  2019-04

10.  Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis.

Authors:  Jianglei Ma; Xiaoyao Li; Shifu Zhao; Jiawei Wang; Wujia Zhang; Guangyuan Sun
Journal:  BMC Cancer       Date:  2021-05-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.